Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
CPT: Pharmacometrics & Systems Pharmacology
|
May 12, 2025
Comprehensive Safety Exposure-Response Analysis to Support Ritlecitinib Dose Selection
Yeamin Huh, Ruolun Qiu, John Prybylski, et al.
Cancer Chemotherapy and Pharmacology
|
July 5, 2015
Integrated nonclinical and clinical risk assessment of the investigational proteasome inhibitor ixazomib on the QTc interval in cancer patients
Neeraj Gupta, Yeamin Huh, Matthew M Hutmacher, et al.
The AAPS Journal
|
January 24, 2024
Virtual Bioequivalence Assessment of Ritlecitinib Capsules with Incorporation of Observed Clinical Variability Using a Physiologically Based Pharmacokinetic Model
Anas Saadeddin, Vivek Purohit, Yeamin Huh, et al.
The AAPS Journal
|
February 21, 2024
Correction: Virtual Bioequivalence Assessment of Ritlecitinib Capsules with Incorporation of Observed Clinical Variability Using a Physiologically Based Pharmacokinetic Model
Anas Saadeddin, Vivek Purohit, Yeamin Huh, et al.
British Journal of Clinical Pharmacology
|
May 7, 2025
Drug-drug interaction profile of ritlecitinib as perpetrator and victim through cytochrome P450
Vivek S Purohit, Yeamin Huh, Martin E Dowty, et al.
The AAPS Journal
|
March 28, 2023
Leveraging Prior Healthy Participant Pharmacokinetic Data to Evaluate the Impact of Renal and Hepatic Impairment on Ritlecitinib Pharmacokinetics
Vivek Purohit, Yeamin Huh, Jessica Wojciechowski, et al.
Pediatric Dermatology
|
February 10, 2025
A Phase 1, Open-Label Study of the Pharmacokinetics of Ritlecitinib in Children Aged 6-12 Years With Alopecia Areata
Mercedes E Gonzalez, John Browning, Stacy Smith, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
November 1, 2019
Cardiac risk assessment based on early Phase I data and PK-QTc analysis is concordant with the outcome of thorough QTc trials: an assessment based on eleven drug candidates
Puneet Gaitonde, Yeamin Huh, Borje Darpo, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
February 13, 2010
Preparation and evaluation of spray-dried hyaluronic acid microspheres for intranasal delivery of fexofenadine hydrochloride
Yeamin Huh, Hyun-Jong Cho, In-Soo Yoon, et al.
European Journal of Drug Metabolism and Pharmacokinetics
|
March 30, 2024
Assessment of the Effects of Abrocitinib on the Pharmacokinetics of Probe Substrates of Cytochrome P450 1A2, 2B6 and 2C19 Enzymes and Hormonal Oral Contraceptives in Healthy Individuals
Xiaoxing Wang, Martin E Dowty, Sakambari Tripathy, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
CPT: Pharmacometrics & Systems Pharmacology
|
May 12, 2025
Comprehensive Safety Exposure-Response Analysis to Support Ritlecitinib Dose Selection
Yeamin Huh, Ruolun Qiu, John Prybylski, et al.
Cancer Chemotherapy and Pharmacology
|
July 5, 2015
Integrated nonclinical and clinical risk assessment of the investigational proteasome inhibitor ixazomib on the QTc interval in cancer patients
Neeraj Gupta, Yeamin Huh, Matthew M Hutmacher, et al.
The AAPS Journal
|
January 24, 2024
Virtual Bioequivalence Assessment of Ritlecitinib Capsules with Incorporation of Observed Clinical Variability Using a Physiologically Based Pharmacokinetic Model
Anas Saadeddin, Vivek Purohit, Yeamin Huh, et al.
The AAPS Journal
|
February 21, 2024
Correction: Virtual Bioequivalence Assessment of Ritlecitinib Capsules with Incorporation of Observed Clinical Variability Using a Physiologically Based Pharmacokinetic Model
Anas Saadeddin, Vivek Purohit, Yeamin Huh, et al.
British Journal of Clinical Pharmacology
|
May 7, 2025
Drug-drug interaction profile of ritlecitinib as perpetrator and victim through cytochrome P450
Vivek S Purohit, Yeamin Huh, Martin E Dowty, et al.
The AAPS Journal
|
March 28, 2023
Leveraging Prior Healthy Participant Pharmacokinetic Data to Evaluate the Impact of Renal and Hepatic Impairment on Ritlecitinib Pharmacokinetics
Vivek Purohit, Yeamin Huh, Jessica Wojciechowski, et al.
Pediatric Dermatology
|
February 10, 2025
A Phase 1, Open-Label Study of the Pharmacokinetics of Ritlecitinib in Children Aged 6-12 Years With Alopecia Areata
Mercedes E Gonzalez, John Browning, Stacy Smith, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
November 1, 2019
Cardiac risk assessment based on early Phase I data and PK-QTc analysis is concordant with the outcome of thorough QTc trials: an assessment based on eleven drug candidates
Puneet Gaitonde, Yeamin Huh, Borje Darpo, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
February 13, 2010
Preparation and evaluation of spray-dried hyaluronic acid microspheres for intranasal delivery of fexofenadine hydrochloride
Yeamin Huh, Hyun-Jong Cho, In-Soo Yoon, et al.
European Journal of Drug Metabolism and Pharmacokinetics
|
March 30, 2024
Assessment of the Effects of Abrocitinib on the Pharmacokinetics of Probe Substrates of Cytochrome P450 1A2, 2B6 and 2C19 Enzymes and Hormonal Oral Contraceptives in Healthy Individuals
Xiaoxing Wang, Martin E Dowty, Sakambari Tripathy, et al.
Page
of 3